Michael Sporn: A legacy of greater knowledge
Elie Dolgin • August 17, 2017
For the love of discovery, a biochemist freely shared the research which laid the groundwork for widely-used drugs.
At 84, retired biochemist Michael Sporn leads a quiet life in a restored farmhouse nestled in Vermont’s bucolic White River Valley.
Continue reading here.
Paul Mischel is championing the importance of odd rings of DNA in tumors — and their promise as targets for cancer therapy.
Edits create cells that don’t trigger an immune response, allowing implant recipient to forego immune-suppressing drugs.